Q5147 Injection, aflibercept-ayyh, 1 milligrams
Q-Codes
Also known as: aflibercept biosimilar, Eylea, VEGF inhibitor, anti-VEGF
Injection of aflibercept-ayyh (Eylea), a biosimilar to aflibercept, administered at 1 milligram per dose.
Clinical Context
Used for wet age-related macular degeneration, diabetic macular edema, and retinal vein occlusion. Administered by intravitreal injection monthly or every 8 weeks. Inhibits vascular endothelial growth factor.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.